normative
Blocking Pharma M&A Would Harm Patients
Policies that stop large pharma from buying small biotechs would slow drugs to patients, create inefficient duplication of sales reps calling on the same doctors, and deny investors exits needed to recycle capital into new innovation.
normativepending
Speaker
RodEvidence Quote
“if you don't allow M&A of smaller biotech companies happen, a lot of bad things happen. Drugs get to patients slower.”
Created: 11/13/2026, 1:54:32 PM
Your notes
Loading notes...